Get started
CANSINO BIOLOGICS INCCANSINO BIOLOGICS INCCANSINO BIOLOGICS INC

CANSINO BIOLOGICS INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

6185 chart


Full chart

6185 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.27 B‬ HKD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.65 HKD
Net income (FY)
‪−410.80 M‬ HKD
Revenue (FY)
‪894.36 M‬ HKD
Shares float
‪70.41 M‬
Beta (1Y)
1.47

Employees


Employees (FY)
‪1.1 K‬
Change (1Y)
−389 −26.04%
Revenue / Employee (1Y)
‪809.37 K‬ HKD
Net income / Employee (1Y)
‪−371.76 K‬ HKD

About CANSINO BIOLOGICS INC


Sector
Health Technology
Industry
Biotechnology
CEO
Xue Feng Yu
Website
cansinotech.com
Headquarters
Tianjin
Founded
2009
ISIN
CNE100003F01
FIGI
BBG00NN6QG15
CanSino Biologics, Inc. engages in the research and development, manufacturing, and sale of vaccines. It offers shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was founded by Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu and Hui Hua Mao on January 13, 2009 and is headquartered in Tianjin, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

6185 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 6185.

Frequently Asked Questions


The current price of 6185 is 30.95 HKD — it has increased by 4.07% in the past 24 hours. Watch CANSINO BIOLOGICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange CANSINO BIOLOGICS INC stocks are traded under the ticker 6185.
6185 stock has fallen by −1.60% compared to the previous week, the month change is a −13.40% fall, over the last year CANSINO BIOLOGICS INC has showed a 73.10% increase.
We've gathered analysts' opinions on CANSINO BIOLOGICS INC future price: according to them, 6185 price has a max estimate of 77.63 HKD and a min estimate of 34.13 HKD. Watch 6185 chart and read a more detailed CANSINO BIOLOGICS INC stock forecast: see what analysts think of CANSINO BIOLOGICS INC and suggest that you do with its stocks.
6185 reached its all-time high on Feb 11, 2021 with the price of 450.00 HKD, and its all-time low was 14.80 HKD and was reached on Feb 5, 2024. View more price dynamics on 6185 chart.
See other stocks reaching their highest and lowest prices.
6185 stock is 3.11% volatile and has beta coefficient of 1.47. Track CANSINO BIOLOGICS INC stock price on the chart and check out the list of the most volatile stocks — is CANSINO BIOLOGICS INC there?
Today CANSINO BIOLOGICS INC has the market capitalization of ‪7.59 B‬, it has decreased by −1.21% over the last week.
Yes, you can track CANSINO BIOLOGICS INC financials in yearly and quarterly reports right on TradingView.
CANSINO BIOLOGICS INC is going to release the next earnings report on Apr 29, 2025. Keep track of upcoming events with our Earnings Calendar.
6185 earnings for the last quarter are −0.67 HKD per share, whereas the estimation was −0.65 HKD resulting in a −3.50% surprise. The estimated earnings for the next quarter are −0.0015 HKD per share. See more details about CANSINO BIOLOGICS INC earnings.
6185 net income for the last quarter is ‪−169.22 M‬ HKD, while the quarter before that showed ‪3.23 M‬ HKD of net income which accounts for ‪−5.35 K‬% change. Track more CANSINO BIOLOGICS INC financial stats to get the full picture.
As of Apr 23, 2025, the company has ‪1.1 K‬ employees. See our rating of the largest employees — is CANSINO BIOLOGICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CANSINO BIOLOGICS INC EBITDA is ‪−207.28 M‬ HKD, and current EBITDA margin is −24.31%. See more stats in CANSINO BIOLOGICS INC financial statements.
Like other stocks, 6185 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CANSINO BIOLOGICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CANSINO BIOLOGICS INC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CANSINO BIOLOGICS INC stock shows the sell signal. See more of CANSINO BIOLOGICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.